Clinical trial · Interventional
Lower-Limb Drainage Mapping in Pelvic Lymphadenectomy for Gynaecological Cancer
Individualisation du Drainage Lymphatique Des Membres inférieurs Lors du Curage Pelvien Pour Cancer gynécologique
NCT01946672CI-TRIAL-00063086SENTIJAMBEcompletedPhase 4ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to evaluate the feasibility of an isotopic technique to identify, and to map the lower-limb drainage nodes during pelvic lymphadenectomy for gynaecological cancers. The diagnostic value of our mapping method will be assessed, and we will determine the incidence of lymhedema.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gynaecological Malignant Tumours With Indication of Pelvic Lymphadenectomy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Lower-limb drainage isotopic intraoperative detection | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- isotopic intraoperative detection
- description
- Lower-limb drainage isotopic intraoperative detection
- interventionNames
- Procedure: Lower-limb drainage isotopic intraoperative detection
Primary outcomes (1)
- measure
- Lower-limb drainage intraoperative isotopic detection rate in patients with pelvic lymphadenectomy for gynaecological cancers.
- timeFrame
- day of surgery
Secondary outcomes (3)
- measure
- Anatomy of lower-limb drainage
- timeFrame
- day of surgery
- measure
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Female patients 18 years of age or older with indication of pelvic lymphadenectomy for gynaecological malignancy: * High risk endometrial cancer (stage IB type I grade 3, stage I type II, stage\> IB) or with metastatic sentinel lymph node, * Early cervical cancer, or with metastatic sentinel lymph node, * Ovarian cancer. * Must provide her signed and informed consent * Beneficiary of a health insurance * Having received a medical examination Exclusion Criteria: * Contraindication to pelvic lymphadenectomy * Presence of lymphedema of the lower limbs * Contraindication to radiomarkers (allergy or hypersensitivity to any component of the biomarker) * Patient with dementia or altered mental status * Pregnant or breast feeding patients * Participation in any other clinical trial that could interfere with the study results
References
Publications (0)
Data not yet available
No reference posted for this study.